BKYI
Bio-key International·NASDAQ
--
--(--)
--
--(--)
BKYI fundamentals
Bio-key International (BKYI) expects to report earnings on Mar 31, 2026, with estimated revenue of 2.20M (YoY +50.45%), and EPS at -0.07 (YoY +86.79%).
Revenue estimate / YoY
2.20M
+50.45%
EPS estimate / YoY
-0.07
+86.79%
Report date
Mar 31, 2026
BKYI Earnings Call Summary for Q4,2025
- Q1 2026 Revenue Surge: $2.2 million (37% YoY), driven by 30% increase in key customer contract and EMEA transition.
- Hardware Growth: 2025 Hardware revenue up 100%, Services up 6%, despite overall 12% revenue decline.
- Margin Improvement: Gross margin 77.5%, License Fee margin 91%, reflecting BIO-key-branded focus.
- Product Momentum: EcoID III and PortalGuard 7.0 targeting regulated industries, with multi-tenant management and mobile features.
- Breakeven Target: 2026 goal with $2.7 million cash, 11% SG&A reduction, and AI efficiency initiatives.
- Market Trends: 70% enterprises moving to passwordless, defense and financial sectors leading adoption.
EPS
Actual | -11.52 | -8.64 | -3.24 | -1.62 | -2.7 | -2.34 | -4.68 | -2.16 | -3.78 | -5.22 | -11.16 | -1.08 | -2.88 | -1.44 | -5.54 | -0.32 | -1 | -0.39 | -0.53 | -0.16 | -0.2 | -0.15 | |||||||||
Forecast | -5.76 | -1.44 | -2.88 | -2.88 | -1.8 | -1.98 | -2.7 | -3.96 | -1.44 | -2.88 | -4.86 | -4.86 | -3.24 | -4.32 | -1.26 | -0.54 | -0.39 | -0.35 | -0.24 | -0.15 | -0.12 | -0.07 | |||||||||
Surprise | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -100.00% | -500.00% | -12.50% | +43.75% | -50.00% | -18.18% | -73.33% | +45.45% | -162.50% | -81.25% | -129.63% | +77.78% | +11.11% | +66.67% | -339.68% | 0.00% | -85.19% | 0.00% | -51.43% | +33.33% | -33.33% | -25.00% | 0.00% |
Revenue
Actual | -- | -- | -- | -- | -- | -- | -- | -- | 307.14K | 943.33K | 1.06M | 1.89M | 992.09K | 1.30M | 934.93K | 1.94M | 1.95M | 1.37M | 1.76M | 3.08M | 1.93M | 1.83M | 2.22M | 2.18M | 1.14M | 2.14M | 1.46M | 1.61M | 1.70M | 1.55M | -- |
Forecast | -- | -- | -- | -- | -- | -- | -- | -- | 1.57M | 910.00K | 1.35M | 1.25M | 1.95M | 1.50M | 1.40M | 1.25M | 2.50M | 2.40M | 1.74M | 2.00M | 2.20M | 1.50M | 2.20M | -- | 2.00M | 2.14M | 2.30M | 1.30M | 1.70M | 1.80M | 2.20M |
Surprise | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -80.44% | +3.66% | -21.20% | +51.09% | -49.12% | -13.41% | -33.22% | +55.29% | -22.12% | -42.77% | +1.06% | +54.19% | -12.32% | +21.89% | +0.71% | 0.00% | -42.94% | 0.00% | -36.42% | +23.63% | -0.18% | -13.91% | 0.00% |
Earnings Call
You can ask Aime
What were the key takeaways from Bio-key International’s earnings call?What does Bio-key International do and what are its main business segments?What is Bio-key International's gross profit margin?What guidance did Bio-key International's management provide for the next earnings period?What is the market's earnings forecast for Bio-key International next quarter?What is Bio-key International's latest dividend and current dividend yield?What is the revenue and EPS growth rate for Bio-key International year over year?What were the key takeaways from Bio-key International's earnings call?
